Mammography

Latest News


CME Content


In a recent video interview, Amy Patel, M.D., shared her perspective on forthcoming national beast density notification in mammography reporting, emphasized the importance of educating primary care providers on breast density risks, and discussed the ongoing need for coverage of supplemental options for breast cancer screening.

In a recent video interview, Wendie Berg, M.D., Ph.D., discussed the newly issued final rule from the Food and Drug Administration (FDA) requiring a national standard for breast density notification (starting on September 10, 2024) as well as its potential impact in mammography reporting and facilitating supplemental screening for patients with dense breasts.

New research from the American Cancer Society comparing pre-pandemic cancer screening prevalence to the second year of the COVID-19 pandemic in the United States showed a 1.1 million decrease in breast cancer screenings, a 4.4 million decrease in cervical cancer screening and a 600,000 decrease in prostate cancer screenings.

In a new study of 1,232 women diagnosed with breast cancer within a year of a screening mammography exam, researchers found that interval breast cancer was 17 percent more likely in women with dense or extremely dense breasts, and over three times more likely to involve stage 2 or higher primary tumors in comparison to screening-detected breast cancer.

In a new survey that examined perceptions of breast cancer risk among more than 1,800 women who had a recent mammogram, 65 percent noted that being overweight or obese was a greater risk factor than breast density, and over a quarter of those interviewed noted they were not aware that they could reduce their breast cancer risk.

Noting the significant administrative fees for the Independent Dispute Resolution (IDR) process of the No Surprises Act and onerous restrictions that have led to a nearly “non-existent” use of batching of disputed claims in radiology, the American College of Radiology (ACR) has sent formal recommendations to the United States Departments of Health and Human Services, Labor, and Treasury for addressing these issues.

Emerging research suggests combined artificial intelligence (AI) assessment of digital mammography and automated 3D breast ultrasound provides enhanced detection of breast cancer in women with dense breasts and may be a viable alternative in areas where radiologists are scarce.